spacer
Colon Health Centers the smart way to screen
of America, LLC
spacer

Frequently Asked Questions: For GI Physicians

Patients  /  Primary Care Providers  /  GI Physicians  /  Payors

 


Why should GI physicians be interested in partnering with CHC America?

Like it or not, Virtual Colonoscopy/CT Colonography (CTC) is coming and will eventually replace Traditional/Optical Colonoscopy (OP) as the initial colorectal cancer screening modality of choice. Studies featuring the most advanced techniques and standardization show that CTC is equivalent to OP in detecting clinically significant polyps. And that's not all. Advantages in convenience, non-invasiveness, safety, and cost will all contribute to an overall preference for CTC by both patients and third-party payors.

A disaster for the specialty of GI?... Perhaps yes... if GIs refuse to change. But the emergence of CTC does not have to be a disaster if GI physicians embrace it rather that shun it. In fact, GI physicians are actually in a better position for offering CTC as part of a comprehensive patient screening regimen that radiologists or other specialists who might provide stand-alone CTC.

Here's why: For several reasons, CTC is not an ideal stand-alone test, because it has no capability for polyp removal. If used as a stand-alone procedure--as most radiologists who adopt it will likely do--there will be no option for immediate polyp removal, and patients will be forced to face further inconvenience and--worse--the prospect of a second prep. See What are the major limitations of CTC? and What is so innovative about the Colon Health Centers of America CRC screening process?

GI physicians on the other hand, because of their connection to endoscopic services and typical ownership interest in endoscopy centers, are actually in a stronger position to provide a comprehensive range of patient-satisfying, cost-effective colorectal cancer screening services than radiologists or any other provider of CTC. For CHC America, GI physicians are a critical component to our screening model.

CHC America is dedicated to helping GI physicians survive and thrive in the new era of CTC. Please contact us to find out how a partnership with CHC America can help your practice thrive while you provide the most comprehensive, convenient, and patient-satisfying methodology for colorectal cancer.

[top of this page]

What is Virtual Colonoscopy/CT Colonography (CTC)?

CTC is a revolutionary and technologically-advanced new screening test for CRC. CTC is an imaging test that is performed by an advanced CT scanner. Images of the patient's abdomen are taken by the CT scanner. With special software, these images are put together to create a three-dimensional image of the colon. This 3-D image of the colon provides the same view of the inside of the colon that is seen by traditional colonoscopy. In fact, the views provided by CTC, in many ways, are even better than those seen by traditional colonoscopy.

[top of this page]

Why is CT Colonography (CTC) such a breakthrough screening test?

CTC is a non-invasive test. It does not require the insertion of an endoscope throughout the colon. It is quick--completed in about 10-15 minutes. Further, it does not require sedation or anesthesia. Therefore the patient is able to immediately resume all activities, including driving and work.

Recent studies of CTC show that it is as sensitive for detecting polyps and cancers as traditional colonoscopy. In fact, in many ways, the images provided by CTC are even better than those seen by traditional colonoscopy. This is because CTC can often see polyps behind haustral folds of the bowel easier and better than traditional colonoscopy.

Furthermore, unlike traditional colonoscopy, which only sees the inside of the colon, a CTC also provides images of the rest of the abdomen. While CTC images are not a substitute for a complete abdominal CT scan, if one is indicated, these CTC images often detect early cancers and other abnormalities in abdominal organs. Many people have been cured of asymptomatic abdominal cancers because they were detected early by CTC.

With CTC, patients not only receive a very sensitive screening test for CRC, but they also get a chance to detect any other early cancers that might be present in the abdomen.

[top of this page]

What do the research studies show for CTC?

In past years, the results of the research studies on CTC have shown a wide range of sensitivity . There are several reasons for this wide range of sensitivity, including the use different scanning equipment, different reading protocols, different image processing techniques, and varied experience of radiologists.

The best studies have been shown in programs with consistent equipment types, image processing software, reading techniques, and reader training. Pickhardt, et al. performed a multi-center trial of CTC as a screening method for CRC in over 1233 asymptomatic, average risk patients. They maintained a uniformity of training, scanning, and reading techniques. The study authors used strategy using 3-D endoluminal displays as the primary reading source, with clarification and problem-solving in 2-D windows.

This technique resulted in a high sensitivity and specificity (93.9%, 92.2%) for CTC similar to than traditional colonoscopy. Sensitivities and specificities of CTC have continued in the research done by two of the large CTC clinical programs across the country, at the University of Wisconsin, Madison, and the Bethesda National Naval Medical Center.

The National CT Colonography Trial (ACRIN 6664) is another large, multi-center trial of the efficacy of CTC for CRC screening. The results of this study were released in Fall 2007, and validated the findings of Pickhardt, et.al. that CTC was a sensitive and accurate screening test for colorectal cancer.  See ACRIN results.

[top of this page]

Do payors currently reimburse for CTC?

Generally not yet.  But commercial reimbursement is only months away.  The American Cancer Society is expected to release updated colon cancer screening guidelines in early 2008, which will endorse CTC.  This ACS endorsement will open the door for commercial payor reimbursement for CTC.

Further, a bill was recently introduced into Congress that would provide reimbursement for Medicare beneficiaries.

Because of some of the early variability in CTC studies, CTC is still officially considered "investigational" by the AMA, CMS, and the major cancer screening guidelines.

Ironically, tests that are clearly inferior to CTC, such as FOBT, Flex Sig, and DCBE are currently "acceptable" and reimbursed modalities of CRC screening. These tests have a significantly lower sensitivity and specificity for CRC screening compared with CTC.

A small number of commercial payors do currently reimburse for CTC in the state of Wisconsin. The AMA is currently reviewing the possibility of creating a full CPT code for CTC. Commercial payors and Medicare will likely see the benefits of CTC with respect to cost and patient acceptability and will begin to reimburse for it as a screening test.

[top of this page]

What are the major limitations of CTC?

While CTC is a powerful new technology, and a test that most patients prefer over traditional colonoscopy, there are a few limitations. First, CTC has no polyp removal capability. If polyps are detected (approximately 20-30% of average risk patients), a traditional colonoscopy needs to be performed to remove them.

Second, patients who undergo CTC will need to perform a 12 hour, pre-test colon preparation, exactly like patients who undergo traditional colonoscopy.

The innovative process employed by Colon Health Centers of America greatly reduces the impact of these two limitations. The CHC America process allows patients to fully benefit from all the many advantages of CTC, while greatly reducing the impact of the two limitations. (See What is so innovative about the Colon Health Centers of America CRC screening process?)

[top of this page]

What is so innovative about the Colon Health Centers of America?

The CHC America CRC screening process represents the ultimate in patient convenience, comprehensiveness, and safety. The patent-pending CHC America process brings together the best aspects of CTC and traditional colonoscopy, and minimizes the limitations of both, in a way that cannot be replicated elsewhere.

The majority of average risk patients (70-80%) who present for screening will not be found to have colon polyps or other abnormalities that would need to be removed. It is unfortunate that these patients have to undergo the additional risk and inconvenience of a traditional colonoscopy, only to find a "clean" colon. On the other hand, 20-30% of patients will have polyps and early cancers detected on CTC that will need to be removed. It is unfortunate that these patients need to undergo a colon prep for the CTC, and later will be notified that they will have to schedule an appointment for a traditional colonoscopy to remove the abnormalities, and undergo a second colon prep all over again! These patients have every right to be angry!

The CHC America process streamlines and eliminates these problems by creating a "Colon Health Center"--a CTC imaging center together with traditional colonoscopy endoscopy center.

Patients arrive at the Colon Health Center after an overnight colon prep. They receive their CTC, which takes approximately 10-15 minutes. The CTC images will be immediately sent to the CHC America reading site, staffed by the most expert CTC readers in the country. Within one hour's time, the patient's CTC reading will return and the patient will be notified whether or not they have any abnormalities. If they are one of the lucky 70-80% of average risk individuals, they are done and can immediately resume all activities.

If they are among the 20-30% of individuals with polyps or other abnormalities, they will be immediately directed to the co-located endoscopy center where they will undergo a traditional colonoscopy and remove the abnormalities.

No need for a second prep! No second day off work! Pure convenience designed around the needs of patients.

[top of this page]

Why choose Colon Health Centers of America over stand-alone radiology/imaging centers?

CTC is a test that is also offered at stand-alone radiology and imaging centers. But the vast majority of these centers will have no capability to follow-up with a traditional colonoscopy. Therefore, many patients will be forced to take a second day off work and undergo a second colon prep! Who would want to take that risk?

Furthermore, the CTCs done at stand-alone radiology/imaging centers will likely be read by the local staff radiologist. While they may be fine radiologists, they will typically be generalists who read chest x-rays, MRIs, mammograms, ultrasounds, etc. along with CTCs. The radiologists who read CHC America studies are national experts in CTC. In many cases, CTC is all they read--all day, every day. Studies have clearly shown that experience dramatically improves one's ability to read CTCs. With CHC America, you will only have the best CTC readers in America reading your study.

[top of this page]

Is there radiation involved in CTC?

Yes, there is radiation exposure with any x-ray or CT scan. Fortunately, with advances in CT technology the radiation exposure from is minimal and is similar to the environmental radiation exposure that one encounters by being outdoors for a period of time. Equipment used at CHC America centers is the latest technology and therefore performs CTC with the smallest possible radiation exposure.

[top of this page]

Where else can your patients receive a similar comprehensive, same-day process?

The short answer is "no". CHC America has a patent pending with the US Patent and Trademark Office on their innovative and comprehensive, same-day screening methodology in the community. Furthermore, CHC America has a passion for improving patient satisfaction with its CRC screening process. After all, satisfied patients are more likely to get screened and therefore prevent colon continues to improve and perfect this patient-centered approach to CRC screening.

[top of this page]

spacer